company

NORDIC DRUGS AB NORSK AVDELING AV UTENLANDSK FORETAK NUF

0161 OSLO

Return on Equity
−84,5 %
Current Ratio
3,85
Debt-to-Equity Ratio
−2,29
Key figures (NOK)2022
Revenue34 083 000
Net Income5 070 000
Total Assets9 865 000
Total Equity−6 000 000
Income (NOK)2022
Revenue34 083 000
Expenditure27 571 000
Operating Profit6 512 000
Financial Income0
Financial Costs5 000
Financial Balance−5 000
Earnings Before Tax6 507 000
Tax1 436 000
Net Income5 070 000
Balance (NOK)2022
Total Fixed Assets1 674 000
Total Current Assets8 191 000
Total Assets9 865 000
Total Retained Equity−6 000 000
Total Equity−6 000 000
Total Long-Term Debt13 738 000
Total Current Debt2 127 000
Total Equity and Debt9 865 000
Cash flow (NOK)2022
Sales Income34 083 000
Other Income0
Revenue34 083 000
Cost of Goods Sold19 358 000
Salary Costs359 000
Depreciation0
Impairment0
Expenditure27 571 000
Operating Profit6 512 000
Financial Income0
Financial Costs5 000
Financial Balance−5 000
Dividends0
Net Income5 070 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets1 674 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets1 674 000
Stock0
Total Investments0
Cash, Bank3 986 000
Total Current Assets8 191 000
Total Assets9 865 000
Total Equity−6 000 000
Short-Term Group Debt0
Total Long-Term Debt13 738 000
Creditors397 000
Unpaid Taxes1 456 000
Dividends0
Other Current Debt274 000
Total Current Debt2 127 000
Total Equity and Debt9 865 000
Financial indicators2022
Return on Equity−84,5 %
Debt-to-Equity Ratio−2,29
Operating Profit Margin19,11 %
Current Ratio3,85
Quick Ratio3,85
Equity Ratio−0,61
Gross Profit Margin43,2 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English